Premama Overview
- Founded
-
2011

- Status
-
Private
- Employees
-
7

- Latest Deal Type
-
Later Stage VC
- Investors
-
20
Premama General Information
Description
Developer of medical supplements designed to soothe symptoms of morning sickness. The company offers prenatal nutritions that are vegan, gluten-free, and non-genetically modified organisms (non-GMO) which minimize iron-induced constipation, enabling women to stay healthy during pregnancy and keep their newborns safe.
Contact Information
Website
www.premamawellness.com
Formerly Known As
Priwater
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Consumer Non-Durables
Other Industries
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Primary Office
- 244 Weybosset Street
- 2nd Floor, Suite 3
- Providence, RI 02903
- United States
+1 (401) 000-0000
Premama Timeline
Premama Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
9. Later Stage VC | 01-Jan-2022 | 000.00 | Completed | Generating Revenue | ||
8. Secondary Transaction - Private | 01-Nov-2021 | 000.00 | Completed | Generating Revenue | ||
7. Later Stage VC (Series D) | 08-Feb-2021 | 00.00 | 000.00 | 000.00 | Completed | Generating Revenue |
6. Later Stage VC (Series C) | 28-Apr-2020 | 00.00 | 00.000 | 0000 | Completed | Generating Revenue |
5. Debt - General | 26-Dec-2017 | 00.000 | Completed | Generating Revenue | ||
4. Later Stage VC (Series B) | 01-Mar-2017 | 00.000 | 00.000 | 000.00 | Completed | Generating Revenue |
3. Early Stage VC (Series A) | 07-Oct-2015 | 00.00 | 00.000 | 00.00 | Completed | Generating Revenue |
2. Angel (individual) | 01-Apr-2014 | $520K | $520K | Completed | Startup | |
1. Grant | $25K | Completed | Startup |
Premama Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series D | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Series C | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Series B | 1,270,937 | $0.010000 | 5% | $2.6 | $2.6 | 1x | $2.6 | 13.8% |
Series A | 1,165,065 | $0.010000 | 5% | $1.65 | $1.65 | 1x | $1.65 | 12.65% |
Premama Patents
Premama Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20220048024-A1 | Test strip holder | Active | 14-Aug-2020 | 0000000000 | 0 |
US-11517896-B2 | Test strip holder | Active | 14-Aug-2020 | 0000000000 | 00 |
US-D675937-S1 | Multi-serving packet | Active | 12-Apr-2012 |
Premama Executive Team (5)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Robert Aziz | Founder, Chief Executive Officer, President & Board Member | ||
Bill Lassell | Chief Financial Officer | ||
Debbie Wilson | Controller |
Premama Board Members (11)
Name | Representing | Role | Since |
---|---|---|---|
Arlene Dickinson | Self | Board Member | 000 0000 |
Christopher Craig | Self | Board Member & Senior Advisor | 000 0000 |
Diane Nordin | Self | Board Member | 000 0000 |
Raymond Mathieu | Cherrystone Angel Group | Board Member | 000 0000 |
Richard Katzman | Self | Board Member | 000 0000 |
Premama Signals
Premama Investors (20)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Nikhil Mandrekar | Angel (individual) | Minority | 000 0000 | 000000 0 | |
North 50 Venture Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
Ryan Craver | Angel (individual) | Minority | 000 0000 | 000000 0 | |
District Ventures Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
Geoff Beattie | Angel (individual) | Minority | 000 0000 | 000000 0 |